AURX (Nuo Therapeutics) OCF Margin %: -60.22% (As of Mar. 2026)

What is Nuo Therapeutics OCF Margin %?

Nuo Therapeutics AURX 33 OCF Margin % is -60.22% as of Mar. 2026. GuruFocus rates AURX with a GF Score™ of 33/100 and a GF Value™ of $4.23 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Nuo Therapeutics ranks better than 54.22% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Nuo Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-0.78 Mil. Nuo Therapeutics's Revenue for the three months ended in Mar. 2026 was $1.30 Mil. Therefore, Nuo Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was -60.22%.

As of today, Nuo Therapeutics's current OCF Yield % is -3.38%.

The historical rank and industry rank for Nuo Therapeutics's OCF Margin % or its related term are showing as below:

AURX' s OCF Margin % Range Over the Past 10 Years
Min: -3308.93 Med: -163.52 Max: -2.74
Current: -39.99

During the past 13 years, the highest OCF Margin % of Nuo Therapeutics was -2.74%. The lowest was -3308.93%. And the median was -163.52%.

AURX's OCF Margin % is ranked better than
54.22% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs AURX: -39.99

Nuo Therapeutics OCF Margin % Related Terms

Nuo Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Nuo Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuo Therapeutics OCF Margin % Chart

Nuo Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

0.00

-3,308.93

-520.20

-163.52

-26.10

Nuo Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															0.41	37.43	-68.51	-38.56	-60.22

AURX vs ACTU, ESLA, LTRN: OCF Margin % Comparison

For the Biotechnology subindustry, Nuo Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuo Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuo Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Nuo Therapeutics's OCF Margin % falls into.

Save Embed

33GF Score

Nuo Therapeutics Inc AURX

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nuo Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Nuo Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-0.865	/	3.314
	=	-26.10 %

Nuo Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-0.784	/	1.302
	=	-60.22 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -60.22% mean?

Nuo Therapeutics (AURX) has a OCF Margin % of -60.22% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nuo Therapeutics and its competitors. According to the industry distribution chart, Nuo Therapeutics ranks #439 out of 959 companies in the Biotechnology industry, placing it in the top 45.8%.

Is Nuo Therapeutics' OCF Margin % too high?

Nuo Therapeutics' current OCF Margin % is -60.22%. Based on the distribution chart, Nuo Therapeutics ranks #439 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Nuo Therapeutics has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Nuo Therapeutics' OCF Margin % compare to ACTU and ESLA?

According to the Biotechnology industry distribution chart, Nuo Therapeutics ranks #439 out of 959 companies for OCF Margin %. This puts Nuo Therapeutics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nuo Therapeutics and its competitors. Nuo Therapeutics's current OCF Margin % is -60.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nuo Therapeutics stock overvalued right now?

Based on GuruFocus' analysis, Nuo Therapeutics (AURX) is currently considered Possible Value Trap. The stock's GF Value™ is $4.23, compared to a current price of $1.01 — trading 76.1% below its estimated fair value. The current OCF Margin % is -60.22%. Nuo Therapeutics' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Nuo Therapeutics (AURX), the current OCF Margin % is -60.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nuo Therapeutics (AURX) Overvalued in 2026?

Based on GuruFocus' analysis, Nuo Therapeutics stock appears to be undervalued. The current stock price of $1.01 is trading 76.1% below its estimated GF Value™ of $4.23. GuruFocus considers Nuo Therapeutics to be Possible Value Trap.

Key valuation signals for AURX:

OCF Margin %: -60.22%
GF Value™: $4.23 vs. price of $1.01 (76.1% below fair value)
GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the AURX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nuo Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies ACTU ESLA LTRN ATOS MGX HYPD NTRB ATYR GOSS KALA VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 8285 El Rio Street, Suite 190, Houston, TX, USA, 77054

Website https://www.nuot.com

Nuo Therapeutics Inc is a commercial-stage medical device company engaged in developing and marketing products for chronic wound care. The company operates as a single segment focused on regenerative therapies that utilize autologous (patient-derived) biological materials to promote natural healing. Its primary commercial product is the Aurix System, a point-of-care technology that produces platelet-rich plasma (PRP) therapy from a patient's own blood for use in the treatment of chronic wounds.

33GF Score

Get the complete analysis for AURX

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.01

Price

$4.23

GF Value

View AURX Analysis

See OCF Margin % data for all stocks →